Cite
Intranasal Administration of Apelin-13 Ameliorates Cognitive Deficit in Streptozotocin-Induced Alzheimer's Disease Model via Enhancement of Nrf2-HO1 Pathways.
MLA
Lu, Hai, et al. “Intranasal Administration of Apelin-13 Ameliorates Cognitive Deficit in Streptozotocin-Induced Alzheimer’s Disease Model via Enhancement of Nrf2-HO1 Pathways.” Brain Sciences (2076-3425), vol. 14, no. 5, May 2024, p. 488. EBSCOhost, https://doi.org/10.3390/brainsci14050488.
APA
Lu, H., Chen, M., & Zhu, C. (2024). Intranasal Administration of Apelin-13 Ameliorates Cognitive Deficit in Streptozotocin-Induced Alzheimer’s Disease Model via Enhancement of Nrf2-HO1 Pathways. Brain Sciences (2076-3425), 14(5), 488. https://doi.org/10.3390/brainsci14050488
Chicago
Lu, Hai, Ming Chen, and Cuiqing Zhu. 2024. “Intranasal Administration of Apelin-13 Ameliorates Cognitive Deficit in Streptozotocin-Induced Alzheimer’s Disease Model via Enhancement of Nrf2-HO1 Pathways.” Brain Sciences (2076-3425) 14 (5): 488. doi:10.3390/brainsci14050488.